• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Model Number 1012625-19
Device Problems Difficult to Remove (1528); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/26/2020
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a heavily calcified, moderately tortuous de novo femoral artery.The 9.0x19mm omnilink elite stent delivery system (sds) failed to cross due to the anatomy.Resistance was met with the sheath during withdrawal and the stent dislodged.The dislodged stent was retrieved with a snare.The procedure was completed with a new 8.0x19mm omnilink stent.There was no adverse patient sequela reported.No additional information was provided.
 
Manufacturer Narrative
A visual inspection was performed on the returned stent and the stent dislodgement was confirmed.The reported difficulty to remove was unable to be confirmed due to the returned condition of the device.The reported failure to advance was unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents reported from this lot.There was no damage noted to the sds during the inspection prior to use which suggests a product quality issue with respect to manufacture, design or labeling did not contribute to the reported difficulties.The investigation determined the reported failure to advance, difficulty to remove and stent dislodgement appear to be related to operational circumstances of the procedure.Based on the reported information, the stent delivery system (sds) encountered resistance with the anatomy resulting in the failure to advance, likely causing damage to the stent resulting in the difficulty to remove through the guiding catheter.Manipulation against resistance ultimately resulted in the stent dislodgement.The noted stent damages likely occurred during retraction with the snare device.Additionally, the reported treatment appears to be related to the operational context of the procedure as the dislodged stent was retrieved with a snare.There is no indication of a product quality issue with respect to the design, manufacture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE PERIPHERAL STENT SYSTEM
Type of Device
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11013087
MDR Text Key222078524
Report Number2024168-2020-10531
Device Sequence Number1
Product Code NIO
UDI-Device Identifier08717648179327
UDI-Public08717648179327
Combination Product (y/n)N
PMA/PMN Number
P110043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Model Number1012625-19
Device Catalogue Number1012625-19
Device Lot Number0031841
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/14/2021
Initial Date Manufacturer Received 11/26/2020
Initial Date FDA Received12/15/2020
Supplement Dates Manufacturer Received01/28/2021
Supplement Dates FDA Received02/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
6F MEDIKIT GUIDING CATHETER
Patient Outcome(s) Required Intervention;
-
-